Demonstrate the value of oncology treatments with real-world evidence you can trust

Unanswered questions represent critical barriers to patient care. HEOR, RWE and Medical Affairs teams leverage Flatiron's trusted data, methodologies, and analytic support to close those gaps and move regulators, payers, and physicians to act.

Real-world clarity drives confident oncology decisions

rwd-thumb-600x400

Real-World Data

Our high-fidelity RWD has the global scale, clinical breadth and depth, timeliness, and quality you need to develop rigorous, trustworthy evidence for all your stakeholders.

telescope-thumb-600x400

AI-Powered Insights

Use Flatiron Telescope’s seamless natural language interface, highly-intuitive LLM tools, and integrated analytical capabilities to tap into our datasets and develop powerful new insights.

rwe-insights-thumb-600x400

Expertise

With thousands of complex studies and peer-reviewed publications under their belt, proven to hold up to HTA and FDA scrutiny, our experts can help you optimize your study design and drive rigorous execution.

What type of evidence study are you planning?

  • Cost effectiveness study

  • Comparative effectiveness study

  • Treatment pattern assessment

  • Natural history and burden of illness

  • Post-marketing safety surveillance


  • Indirect treatment comparisons

  • Long term survival analysis

  • Healthcare resource utilization

  • Clinical decision making analysis

  • Adverse event / drug safety studies

by the numbers

5M+

research-ready patients today, 10M+ by 2030

15+

years of longitudinal oncology data

2.7M+

ML-extracted data points

2,000+

peer-reviewed publications powered by Flatiron RWD

Real-world insights for HEOR, RWE and Medical Affairs teams

Connect with Flatiron's HEOR, RWE and Medical Affairs experts